The biopharma industry is evolving, with increased focus on partnerships, early-phase deal-making and technologies like AI and machine learning. At this year’s BIO-Europe conference in Stockholm, Norstella’s subject matter experts joined discussions on key topics, including a roundtable on the future of precision medicine and a panel on the pharma patent cliff, highlighting the role of collaboration and data-driven strategies in tackling industry challenges.
Following the event, Izabela Chmielewska, Citeline’s managing editor of custom content, hosted a podcast with Kevin Grogan, managing editor of Scrip and Natasha Choukkar, senior manager of portfolio advisory strategy consulting at Evaluate, to share insights on advancing personalized treatments and sustaining growth through innovation.
The conversation underscored how Norstella’s data, analytics, and consulting capabilities support organizations in addressing challenges and capturing opportunities in an ever-changing landscape.
For more information on Norstella’s solutions, visit: Our solutions | Norstella
Managing Editor, Custom Content | Citeline
Managing Editor | Scrip
Senior Manager, Portfolio Advisory Strategy Consulting | Evaluate
We’re looking for agile, growth-oriented team players who are passionate about client success and helping clients bring life-saving therapies to market quicker—and help patients in need.
Work with usHave questions about Norstella or its brands? Or do you want to know more about how to solve your challenges at each stage of the drug life cycle?
We want to hear from you